Skip to content

Expert@Work - Effectiveness of a Digital Expert Team on Return to Work

Expert@Work - Effectiveness of a Digital Expert Team on Return to Work

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05575908
Acronym
Expert@Work
Enrollment
170
Registered
2022-10-12
Start date
2022-10-13
Completion date
2028-12-31
Last updated
2026-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental Disorder, Musculoskeletal Diseases

Brief summary

Long-term sick leave is a challenge in Norway, and the healthcare and labor- and welfare services are often not coordinated in helping the sick-listed employees return to work. In this study, the investigators want to evaluate the effectiveness of an intervention where an expert team provides advice for an individualized patient pathway based on information from a digital questionnaire and a video meeting with the sick-listed employee and the participant's general practitioner. The patient pathway should include both healthcare and labor- and welfare services measures. Sick-listed patients with musculoskeletal- and/or common mental disorders are invited to join the study. They will receive a digital questionnaire and be randomized to either treatment as usual or personalized advice from an expert team. The team will be put together based on the response from the individual's questionnaire. The investigators will evaluate the effect on return to work and the use of health care services 12 months after the intervention.

Interventions

PROCEDUREDigital expert team

A digital team will be appointed based on the participant's answers in the digital screening questionnaire. Members of the team can be specialists in Physical and rehabilitation medicine, psychologist, physiotherapist, social workers, and consultants in the labor- and welfare administration. The general practitioner will also be invited to the meeting.

Sponsors

St. Olavs Hospital
Lead SponsorOTHER
Norwegian Labour and Welfare Administration
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

It is not possible to blind the participants or the care providers. As the investigators also will be care providers in this study, they will also have knowledge of the allocation. After the intervention, all data will be depersonalized and the name and other identifiers will be replaced by a study number. The outcome will be collected from national registries and the merging of data will be done by a statistician in the labor- and welfare administration who is not involved in the assessment of data. This allows the researchers to be blinded when they analyze the data.

Intervention model description

Sick-listed employees with musculoskeletal disorders and/or common mental disorders will receive an invitation to the study from the labor-and welfare administration. Individuals who consent to participate will be allocated to either treatment as usual or personalized advice from an expert-team.

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Sick-listed minimum 50% between 11 and 20 weeks * Musculoskeletal disorder and/or common mental disorder * Living in the county of Trøndelag or Møre- og Romsdal

Exclusion criteria

* Specific conditions such as fracture, trauma, infections, malignancy, dislocations, etc. * Serious mental conditions or another serious disease that makes participation difficult * Most likely to return to work within 2 weeks * Not speaking/reading Norwegian

Design outcomes

Primary

MeasureTime frameDescription
Return to work12 monthsTime to return to work within 12 months for at least 4 consecutive weeks

Secondary

MeasureTime frameDescription
Function12 monthsApprovement in function measured by Versus Arthritis Musculoskeletal Health Questionnaire (MSK-HQ). The MSK-HQ is scored on a range of 0-56, with a better score indicating better MSK-HQ health status
Change in pain12 monthsChange in pain measured on a numeric rating scale (0-10), with a higher score indicating more pain
Change in depression symptoms12 monthsImprovement in depression symptoms measured by Patient Health Questionnaire-9 (PHQ-9). PHQ-9 is scored on a range of 0-27, with higher score indicating more serious symptoms
Change in anxiety symptoms12 monthsImprovement in anxiety symptoms measured by Generalized Anxiety Disorder 7-item (GAD-7). GAD-7 is scored on a range of 0-21, with higher score indicating more serious symptoms
Days lost from work12 monthsLost workdays during one year after intervention

Countries

Norway

Contacts

STUDY_DIRECTORGunn Hege Marchand, PhD

St. Olavs hospital HF

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 22, 2026